Hummel Kornelia, Sachse Michaela, Hoffmann Johannes J M L, van Dun Ludi P J M
MEDILYS Laboratories LmbH, Central Laboratory of the Asklepios Clinics, Hamburg, Germany.
Medical & Scientific Affairs, Abbott Hematology, Wiesbaden-Delkenheim, Germany.
Transfusion. 2018 Oct;58(10):2301-2308. doi: 10.1111/trf.14886. Epub 2018 Sep 17.
Decisions on prophylactic platelet (PLT) transfusions are generally based on the recipient's PLT count, but few clinicians are aware of precision and accuracy of the PLT counting methods used by the clinical laboratory. Each PLT counting technology has its specific inaccuracy, especially in thrombocytopenic samples and therefore may impact decisions on PLT transfusions.
Five routine PLT counting methods available in two hematology analyzers (Sysmex XN-2000 and Abbott CELL-DYN Sapphire) were investigated (impedance and optical on both analyzers and fluorescent on XN-2000), using the CD61 immunologic PLT method as a reference. The impact of counting inaccuracy on imaginary transfusion decisions was examined at various common PLT thresholds.
In total 341 samples were analyzed, 178 of which had PLT counts of less than 35 × 10 /L. Despite excellent overall correlation with the reference method (r > 0.99), thrombocytopenic samples showed only modest correlation for impedance and XN-2000 optical methods. Sapphire optical and XN-2000 fluorescent methods correlated very well with the reference, albeit with bias in the very low range. We noticed potential risk of undertransfusion (ranging from 2% to 90%), depending on the threshold used. The risk of overtransfusion was small (<10%).
The XN-2000 fluorescent PLT counting method showed excellent correlation with the CD61 reference count, closely followed by the CELL-DYN Sapphire optical method. XN-2000 impedance and optical and Sapphire impedance methods are not accurate enough for basing transfusion decisions on. Only XN-2000 fluorescent, Sapphire optical, and CD61 methods are sufficiently accurate for making appropriate clinical decisions in patients with severe thrombocytopenia.
预防性血小板(PLT)输注的决策通常基于受者的PLT计数,但很少有临床医生了解临床实验室使用的PLT计数方法的精密度和准确性。每种PLT计数技术都有其特定的不准确性,尤其是在血小板减少样本中,因此可能会影响PLT输注的决策。
使用CD61免疫血小板方法作为参考,研究了两种血液分析仪(Sysmex XN - 2000和雅培CELL - DYN Sapphire)中可用的五种常规PLT计数方法(两种分析仪的阻抗法和光学法以及XN - 2000的荧光法)。在各种常见的PLT阈值下,检查计数不准确性对虚拟输血决策的影响。
共分析了341个样本,其中178个样本的PLT计数低于35×10⁹/L。尽管与参考方法总体相关性良好(r>0.99),但血小板减少样本的阻抗法和XN - 2000光学法仅显示出适度的相关性。Sapphire光学法和XN - 2000荧光法与参考方法相关性非常好,尽管在极低范围内存在偏差。我们注意到根据所使用的阈值,存在输血不足的潜在风险(范围从2%到90%)。输血过度的风险较小(<10%)。
XN - 2000荧光PLT计数方法与CD61参考计数显示出极好的相关性,其次是CELL - DYN Sapphire光学方法。XN - 2000阻抗法、光学法和Sapphire阻抗法的准确性不足以作为输血决策的依据。只有XN - 2000荧光法、Sapphire光学法和CD61方法对于严重血小板减少患者做出适当的临床决策足够准确。